. Plexin-A isoforms are expressed in normal and diabetic nonwounded and wounded corneal epithelium and trigeminal ganglia. Streptozotocin-induced diabetes mellitus (DM) and age-matched normal (NL) mice were wounded by epithelium-debridement (1.5mm-diameter) and collected at 20 hours post-wounding. Corneal epithelium (K) and Trigeminal ganglia (TGN) before wounding were collected as non-wounded controls alongside the normal (NLW) and diabetic (DMW) healing K and TGN and were subjected to RNA isolation and reverse transcription. Regular PCR analysis was performed for 4 Plexin-A all isoforms with actin as an internal loading control. Two independent experiments were performed.
. NRP isoforms are expressed by CD11C-positive round infiltrating cells, but not residential dendriform CD11C-positive cells. Corneas from normoglycemic mice were wounded by epithelium-debridement (1.5mm-diameter) and collected at 20 hours post-wounding as whole mounts. The treated corneas were co-stained with CD11C (red) and NRP1 or NRP2 (green). Two morphologies of CD11C-positive cells were identified: dendriform-shaped and round-shaped. Only round-shaped CD11c-positive infiltrating cells costained with either NRP antibody. Arrows mark residential dendriform-shaped CD11C-positive cells that did not costain with either NRP.
Supplementary Figure 3. Delayed Epithelial Wound Healing Associated with Injection of Sema3C-Specific siRNA is due to
Decreased SEMA3C expression. (A) Corneas of normal mice were pretreated with either a solution of Sema3C-specific siRNA (20 mmol/L) plus BSA (50 ng/uL), or a solution of Sema3C-specific siRNA (20 mmol/L) plus recombinant SEMA3C (50 ng/uL), 24 and 4 h prior to epithelium debridement. At 0 h, the corneas were wounded by epithelium-debridement (1.5mm-diameter) and allowed to heal. At 20 hpw, injured corneas were stained with fluorescein to show remaining wound and photographed. (B) The same procedure was performed for corneas of normal mice were pretreated with either a solution of control (CT) nonspecific siRNA (20 mmol/L) plus BSA (50 ng/uL), or a solution of Sema3C-specific siRNA (20 mmol/L) plus recombinant SEMA3C (50 ng/uL), 24 and 4h prior to epithelium debridement. The wound sizes were calculated using Adobe Photoshop software and presented as average of total pixels (mean ± SD, n = 5). Note that the presence of recombinant SEMA3C in Sema3C-specific siRNA-treated corneas restored knockdownattenuated epithelial wound healing and that Sema3C-specific siRNA + recombinant SEMA3C-treated and control siRNA-treated corneas had the same epithelial wound closure rates.
